Okta, Inc. (NASDAQ:OKTA) experienced an adrenaline-fueled leap in pre-market trading following a triumphant showcase of fourth-quarter financial prowess and the projection of robust guidance. The company trumped expectations by reporting earnings of 63 cents per share, exceeding the analyst-projected 51 cents. Sales for the quarter hit $605 million, outstripping the anticipated $587.5 million, courtesy of data sourced from Benzinga Pro.

In the financiers’ arena, such impressive displays are akin to a talented rookie winning the MVP trophy in their debut season. Okta stock catapulted by 23.6%, landing at $107.90 in the pre-market hustle.

Investors hardly restrained their enthusiasm, scattershot with vibrant energy, as they eagerly speculated how higher prices could unfold. This catapult in Okta shares triggers an in-depth scrutiny of other star performers in the pre-market trading domain.

Gargantuan Gainers

• Volcon, Inc. (NASDAQ: VLCN) led the charge, with an awe-inspiring climb of 138% to reach $2.88 in pre-market trading post a 39% surge on Wednesday.
• Societal CDMO, Inc. (NASDAQ: SCTL) joined the victors’ podium with shares ascending by a staggering 134.7% to $1.08 in pre-market business, following an acquisition agreement with CoreRx, Inc.
• J-Long Group Limited (NASDAQ: JL) sprinted skywards by 38.1% to soar at $17.67, after a 20% plunge on Wednesday.
• Voyager Therapeutics, Inc. (NASDAQ: VYGR) notched up a 24.4% gain at $11.16 in pre-market trading, post a robust fourth-quarter financial revelation.
• NXU, Inc. (NASDAQ: NXU) rejoiced in a 21.8% surge to $0.8649 during pre-market activity, fueled by its full compliance reinstatement with Nasdaq’s listing requirements.

Doleful Decliners

• BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) experienced a bleak 25.2% dip to $0.1522 in pre-market trading as it set foot into production agreements for its EZ-G Device.
• Snowflake Inc. (NYSE: SNOW) reeled from a 23% fall to $177.17 in pre-market deliberations. Despite upbeat fourth-quarter earnings, the resignation of CEO Frank Slootman cast a somber shadow, balanced only by Sridhar Ramaswamy’s immediate appointment.
• WW International, Inc. (NASDAQ: WW) slumped by 21.9% to $2.98 in pre-market trading post the revelation of fourth-quarter numbers, compounded by the announcement of Oprah Winfrey’s decision not to seek re-election as a director.
• Envoy Medical, Inc. (NASDAQ: COCH) recoiled by 19.7% to $2.82 in pre-market haggling after surging overwhelmingly by 190% in the preceding session.
• Butterfly Network, Inc. (NASDAQ: BFLY) descended by 18.2% to $1.21 in early trading following a blend of mixed fourth-quarter financial results.

Now Read This: HP, Best Buy And 3 Stocks To Watch Heading Into Thursday